SNCA and Alzheimer disease: In the presence of neurodegenerative disorders, such as pathologically confirmed Alzheimer’s disease (AD), other pathologies such as α-synuclein and TAR DNA-binding protein 43 (TDP-43) co-occur frequently [31, 55, 56].